Whether it’s work or play that prevents us from getting enough shut-eye during the week, assuming we can make up for it by sleeping in over the weekend is a mistake, according to new research led by Penn State. The research, published in Psychosomatic Medicine, reveals that cardiovascular health measures, including heart rate and blood…
Obesity is a significant predictor for obstructive sleep apnea (OSA) severity in children, while older age is a risk factor for residual OSA, researchers at UT Southwestern Medical Center and Children’s Health found. Published in Laryngoscope Investigative Otolaryngology, the study adds to the growing awareness of obesity’s role in pediatric OSA and its associated effects…
Standing before the Roman proconsul, Polycarp knew the end was near. The skilled Roman official methodically questioned him and repeatedly demanded that Polycarp worship a pagan image. Each time he refused. The bloodthirsty crowd filling the amphitheater jeered the Christian bishop. Changing tactics, the proconsul encouraged Polycarp to persuade the people. Polycarp felt no compulsion…
RespireRx Pharmaceuticals Inc, which is developing a dronabinol-based drug to treat obstructive sleep apnea (OSA), and ResolutionRx Ltd, an Australian subsidiary of RespireRx, have entered into a series of bilateral agreements to transfer the RespireRx pharmaceutical cannabinoid program to ResolutionRx and establish it as an operating company. “Since the incorporation of ResolutionRx at the beginning…
Avadel Pharmaceuticals plc provided a second-quarter corporate update detailing the progress following Lumryz’s approval by the US Food and Drug Administration (FDA) during the period and upcoming milestones, including seeking an expanded indication for Lumryz. The FDA approved Lumryz on May 1 as the first and only once-at-bedtime oxybate therapy for the treatment of cataplexy…
Sree Roy: Hello and welcome. I’m Sree Roy with Sleep Review, and I’m thrilled to be here with pulmonologist-sleep specialist Richard K. Bogan, MD. Dr. Bogan is a principal owner of Bogan Sleep Consultants in Columbia, South Carolina, and an experienced chief medical officer, clinician, and researcher. This episode is sponsored by Jazz Pharmaceuticals. Today,…